Oral antigen exposure in extreme early life in lambs influences the magnitude of the immune response which can be generated in later life

BMC Veterinary Research

Heather L Wilson¹  Sonja Mertins¹  Rachelle M Buchanan¹ 

[1] Vaccine and Infectious Disease Organization (VIDO), University of Saskatchewan, Saskatoon S7N 5E3, SK, Canada

关键词: Oral;    Mucosal;    Ovalbumin;    Neonate;    Lambs;   

Others  :  1119478
DOI  :  10.1186/1746-6148-9-160

 received in 2012-10-17, accepted in 2013-08-08,  发布年份 2013

【 摘 要 】

Background

Previous investigations in newborn lambs determined that adenovirus-mediated expression of antigen to a localized region of the gut induced antigen-specific mucosal and systemic immunity. These experiments were limited in that the localized region of the gut to which antigen was introduced was sterile and the influence of colostrum on the antigen was not assessed but they do suggest that mucosal vaccines may be an effective vaccination strategy to protect neonatal lambs. We propose that persistent oral antigen exposure introduced in extreme early life can induce immunity in lambs, despite the presence of commensal bacteria and colostrum.

Results

To test this hypothesis, conventionally raised newborn lambs (n = 4 per group) were gavaged with ovalbumin (OVA) starting the day after birth for either a single day (2.27 g), every day for 3 days (0.23 g/day), or every day for 3 days then every second day until nine days of age (0.023 g/day). Lambs gavaged with OVA for 3 to 9 days developed significant serum anti-OVA IgG titres (p < 0.05), but not IgA titres, relative to control lambs (n = 4) after 3 and 4 weeks. At 4 weeks of age, lambs were immunized with OVA in Incomplete Freund’s Adjuvant via intraperitoneal (i.p.) injection then lambs were euthanized at 7 weeks. Serum anti-OVA IgG titres were further augmented after i.p. immunization indicating immunity persisted and tolerance was not induced. Serum IgA titres remained low regardless of treatment. It is known that i.p. priming of sheep with antigen in Freund’s complete adjuvant leads to an enhanced number of IgA and IgG antibody containing cells in the respiratory mucosa (Immunology 53(2):375–384, 1984). Lambs gavaged with a single bolus of 2.27 g OVA prior to i.p. immunization showed very low titres of anti-OVA IgA in the lung lavage. These data suggest that a single, high dose exposure to OVA can promote tolerance which impacts response to systemic vaccination in later life. Lambs gavaged with 0.023 g OVA for 9 days (Group C) generated significant anti-OVA IgA titres in lung (p < 0.001) compared to negative control lambs but no additive effect was observed compared to parenteral control lambs. When splenocytes were re-stimulated with OVA ex vivo, all groups failed to show increased lymphocyte proliferation or interferon (IFN)-γ production relative to the parenteral control group.

Conclusions

In agreement with our hypothesis, persistent low dose antigen exposure primes humoral antibody production in serum in conventionally raised newborn lambs. In contrast, a single high dose bolus of antigen triggered oral tolerance which negatively impacted the quality and magnitude of the immune response to i.p. immunization in later life. These tangential responses are important as they indicate that the dose and/or repeated oral exposure to antigen, such as that which may be found in the neonate’s environment, may promote immunity or alternatively it may negatively impact responses to parenteral vaccination.

【 授权许可】

   
2013 Buchanan et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]Chappuis G: Neonatal immunity and immunisation in early age: lessons from veterinary medicine. Vaccine 1998, 16(14–15):1468-1472.
• [2]Balamurugan V, Sen A, Venkatesan G, Rajak KK, Bhanuprakash V, Singh RK: Study on passive immunity: Time of vaccination in kids born to goats vaccinated against Peste des petits ruminants. Virol Sin 2012, 27(4):228-233.
• [3]Silverstein AM, Uhr JW, Kraner KL, Lukes RJ: Fetal response to antigenic stimulus. II. Antibody production by the fetal lamb. J Exp Med 1963, 117:799-812.
• [4]Ingram DG, Smith AN: Immunological Responses of Young Animals. I. Review of the Literature. Can Vet J 1965, 6:194-204.
• [5]Cole GJ, Morris B: The growth and development of lambs thymectomized in utero. Aust J Exp Biol Med Sci 1971, 49(1):33-53.
• [6]Faria AMC, Maron R, Ficker SM, Slavin AJ, Spahn T, Weiner HL: Oral tolerance induced by continuous feeding: enhanced up-regulation of transforming growth factor-beta/interleukin-10 and suppression of experimental autoimmune encephalomyelitis. J Autoimmun 2003, 20(2):135-145.
• [7]Faria AMC, Weiner HL: Oral tolerance. Immunol Rev 2005, 206:232-259.
• [8]Strobel S, Mowat AM: Oral tolerance and allergic responses to food proteins. Curr Opin Allergy Clin Immunol 2006, 6(3):207-213.
• [9]Siegrist CA, Cordova M, Brandt C, Barrios C, Berney M, Tougne C, Kovarik J, Lambert PH: Determinants of infant responses to vaccines in presence of maternal antibodies. Vaccine 1998, 16(14–15):1409-1414.
• [10]Hassett DE, Zhang J, Whitton JL: Neonatal DNA immunization with a plasmid encoding an internal viral protein is effective in the presence of maternal antibodies and protects against subsequent viral challenge. J Virol 1997, 71(10):7881-7888.
• [11]Husband AJ, McDowell GH: Local and systemic immune responses following oral immunization of foetal lambs. Immunology 1975, 29(6):1019-1028.
• [12]Richardson M, Conner GH: Prenatal immunization by the oral route: stimulation of Brucella antibody in fetal lambs. Infect Immun 1972, 5(4):454-460.
• [13]Gerdts V, Babiuk LA, van Drunen Littel-van Den H, Griebel PJ: Fetal immunization by a DNA vaccine delivered into the oral cavity. Nat Med 2000, 6(8):929-932.
• [14]Gerdts V, Snider M, Brownlie R, Babiuk LA, Griebel PJ: Oral DNA vaccination in utero induces mucosal immunity and immune memory in the neonate. J Immunol 2002, 168(4):1877-1885.
• [15]Mutwiri G, Bateman C, Baca-Estrada ME, Snider M, Griebel P: Induction of immune responses in newborn lambs following enteric immunization with a human adenovirus vaccine vector. Vaccine 2001, 19(9–10):1284-1293.
• [16]McNeilly TN, McClure SJ, Huntley JF: Mucosal immunity in sheep and implications for mucosal vaccine development. Sm Ruminant Res 2008, 76(1–2):83-91.
• [17]McGhee JR, Xu-Amano J, Miller CJ, Jackson RJ, Fujihashi K, Staats HF, Kiyono H: The common mucosal immune system: from basic principles to enteric vaccines with relevance for the female reproductive tract. Reprod Fertil Dev 1994, 6(3):369-379.
• [18]Mestecky J: The common mucosal immune system and current strategies for induction of immune responses in external secretions. J Clin Immunol 1987, 7(4):265-276.
• [19]Brandtzaeg P: Regionalized immune function of tonsils and adenoids. Immunol Today 1999, 20(8):383-384.
• [20]Czerkinsky C, Holmgren J: Topical immunization strategies. Mucosal Immunol 2010, 3(6):545-555.
• [21]Bourges D, Chevaleyre C, Wang C, Berri M, Zhang X, Nicaise L, Meurens F, Salmon H: Differential expression of adhesion molecules and chemokines between nasal and small intestinal mucosae: implications for T- and sIgA + B-lymphocyte recruitment. Immunology 2007, 122(4):551-561.
• [22]Scicchitano R, Husband AJ, Clancy RL: Contribution of intraperitoneal immunization to the local immune response in the respiratory tract of sheep. Immunology 1984, 53(2):375-384.
• [23]Griebel PJ, Hein WR: Expanding the role of Peyer’s patches in B-cell ontogeny. Immunol Today 1996, 17(1):30-39.
• [24]Harris SP, Hines MT, Mealey RH, Alperin DC, Hines SA: Early development of cytotoxic T lymphocytes in neonatal foals following oral inoculation with Rhodococcus equi. Vet Immunol Immunopathol 2011, 141(3–4):312-316.
• [25]Emery DL, McClure SJ, Davey RJ: Protection of Merino lambs against Haemonchus contortus by trickle infection of neonates. Parasitol Int 2000, 49(2):165-170.
• [26]Emery DL, McClure SJ, Davey RJ, Bendixsen T: Induction of protective immunity to Trichostrongylus colubriformis in neonatal merino lambs. Int J Parasitol 1999, 29(7):1037-1046.
• [27]Mittal SK, Papp Z, Tikoo SK, Baca-Estrada ME, Yoo D, Benko M, Babiuk LA: Induction of systemic and mucosal immune responses in cotton rats immunized with human adenovirus type 5 recombinants expressing the full and truncated forms of bovine herpesvirus type 1 glycoprotein gD. Virology 1996, 222(2):299-309.
• [28]Stott GH, Marx DB, Menefee BE, Nightengale GT: Colostral immunoglobulin transfer in calves I. Period of absorption. J Dairy Sci 1979, 62(10):1632-1638.
• [29]Lorenz RG, Newberry RD: Isolated lymphoid follicles can function as sites for induction of mucosal immune responses. Ann N Y Acad Sci 2004, 1029:44-57.
• [30]Cesta MF: Normal Structure, Function, and Histology of Mucosa-Associated Lymphoid Tissue. Tox Pathol 2006, 34(5):599-608.
• [31]Varol C, Vallon-Eberhard A, Elinav E, Aychek T, Shapira Y, Luche H, Fehling HJ, Hardt WD, Shakhar G, Jung S: Intestinal lamina propria dendritic cell subsets have different origin and functions. Immunity 2009, 31(3):502-512.
• [32]Cerovic V, Houston SA, Scott CL, Aumeunier A, Yrlid U, Mowat AM, Milling SWF: Intestinal CD103- dendritic cells migrate in lymph and prime effector T cells. Mucosal Immunol 2012.
• [33]Buddle BM, Wards BJ, Aldwell FE, Collins DM, de Lisle GW: Influence of sensitisation to environmental mycobacteria on subsequent vaccination against bovine tuberculosis. Vaccine 2002, 20(7–8):1126-1133.
• [34]Sheldrake RF, Husband AJ, Watson DL: Origin of antibody-containing cells in the ovine mammary gland following intraperitoneal and intramammary immunisation. Res Vet Sci 1988, 45(2):156-159.
• [35]Kovacs-Nolan J, Latimer L, Landi A, Jenssen H, Hancock REW, Babiuk LA, Van Drunen Littel-van den Hurk S: The novel adjuvant combination of CpG ODN, indolicidin and polyphosphazene induces potent antibody- and cell-mediated immune responses in mice. Vaccine 2009, 27(14):2055-2064.
• [36]Elahi S, Buchanan RM, Babiuk LA, Gerdts V: Maternal immunity provides protection against pertussis in newborn piglets. Infect Immun 2006, 74(5):2619-2627.
• [37]Wilson HL, Kovacs-Nolan J, Latimer L, Buchanan R, Gomis S, Babiuk L, van Drunen Littel-van den Hurk S: A novel triple adjuvant formulation promotes strong, Th1-biased immune responses and significant antigen retention at the site of injection. Vaccine 2010, 28(52):8288-8299.